Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Delhi Metallo-Beta-Lactamase Facilitates the Emergence of Cefiderocol Resistance in Enterobacter cloacae
Dennis Nurjadi, Kaan Kocer, Quan Chanthalangsy, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 66, Iss. 2
Open Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

Emerging Target-Directed Approaches for the Treatment and Diagnosis of Microbial Infections
Mariana C. Almeida, Paulo Martins da Costa, Emı́lia Sousa, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 32-70
Closed Access | Times Cited: 14
Convergent Klebsiella pneumoniae strains belonging to a sequence type 307 outbreak clone combine cefiderocol and carbapenem resistance with hypervirulence
Katharina Schaufler, Thaddäus Echelmeyer, Michael Schwabe, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 8
Extreme resistance to the novel siderophore-cephalosporin cefiderocol in an extensively drug-resistant Klebsiella pneumoniae strain causing fatal pneumonia with sepsis: genomic analysis and synergistic combinations for resistance reversal
Land Daoud, Mushal Allam, Timothy Collyns, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 11, pp. 1395-1400
Closed Access | Times Cited: 7
Catechol‐Siderophore Mimics Convey Nucleic Acid Therapeutics into Bacteria
Mathijs Pals, Luuk Wijnberg, Çağlar Yildiz, et al.
Angewandte Chemie (2024) Vol. 136, Iss. 19
Open Access | Times Cited: 2
Characterisation of cefiderocol-resistant spontaneous mutant variants of Klebsiella pneumoniae-producing NDM-5 with a single mutation in cirA
Vyanka Mezcord, Germán M. Traglia, Fernando Pasterán, et al.
International Journal of Antimicrobial Agents (2024) Vol. 63, Iss. 5, pp. 107131-107131
Closed Access | Times Cited: 2
In vitro activity assessment of cefiderocol against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp., including β-lactam nonsusceptible molecularly characterized isolates, collected from 2020 to 2021 in the United States and European hospitals
John H. Kimbrough, Joshua Maher, Hélio S. Sader, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 11
Open Access | Times Cited: 2
Successful control of an environmental reservoir of NDM-producing Klebsiella pneumoniae associated with nosocomial transmissions in a low-incidence setting
Estelle Moulin, Paraskevas Filippidis, Corinne Aymon Paire-Ficout, et al.
Antimicrobial Resistance and Infection Control (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Gene sdaB Is Involved in the Nematocidal Activity of Enterobacter ludwigii AA4 Against the Pine Wood Nematode Bursaphelenchus xylophilus
Yu Zhao, Zhibo Yuan, Shuang Wang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 11
High efficacy and enhanced synergistic activity of the novel siderophore-cephalosporin cefiderocol against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae from inpatients attending a single hospital in the United Arab Emirates
Lana Daoud, Farah Al‐Marzooq, Akela Ghazawi, et al.
Journal of Infection and Public Health (2023) Vol. 16, pp. 33-44
Open Access | Times Cited: 6
Cross-contamination of carbapenem-resistant Gram-negative bacteria between patients and the hospital environment in the first year of a newly built surgical ward
Sébastien Boutin, Martin Scherrer, Isabel Späth, et al.
Journal of Hospital Infection (2023) Vol. 144, pp. 118-127
Closed Access | Times Cited: 6
In Vitro Activity of Cefiderocol Compared to Other Antimicrobials against a Collection of Metallo-Beta-Lactamase-Producing Gram-Negative Bacilli from Southern Spain
Mercedes Delgado-Valverde, Inés Portillo-Calderón, Esther Recacha, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 5
The acquisition of transferable extrachromosomal fec operon is associated with a cefiderocol MIC increase in Enterobacterales
Kaan Kocer, Sébastien Boutin, Klaus Heeg, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 12, pp. 3487-3495
Closed Access | Times Cited: 8
Cefiderocol – An effective antimicrobial for MDR infections but a challenge for routine antimicrobial susceptibility testing
Małgorzata Brauncajs, Filip Bielec, Anna Macieja, et al.
Advances in Medical Sciences (2024) Vol. 69, Iss. 2, pp. 256-263
Open Access | Times Cited: 1
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies
Abdullah Tarık Aslan, Murat Akova
Expert Review of Anti-infective Therapy (2024), pp. 1-17
Closed Access | Times Cited: 1
Investigation of cefiderocol resistance prevalence and resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa, Germany 2019–21
Kaan Kocer, Sébastien Boutin, Maximilian Moll, et al.
JAC-Antimicrobial Resistance (2024) Vol. 6, Iss. 6
Open Access | Times Cited: 1
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review
Riyan Babidhan, Abigale Lewis, Cailin Atkins, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2022) Vol. 42, Iss. 7, pp. 549-566
Closed Access | Times Cited: 6
β-Lactam antibiotics
Jed F. Fisher, Yuanyuan Qian, Shahriar Mobashery
Elsevier eBooks (2023), pp. 67-113
Closed Access | Times Cited: 3
Thiazole, a privileged scaffold in drug discovery
Mohammad A. Alam
Elsevier eBooks (2023), pp. 1-19
Closed Access | Times Cited: 3
Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia
Stephanie L Egge, James S. Lewis, Morgan Hakki
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 8
Open Access | Times Cited: 2
L-Aspartic acid pyridinium salts: In silico, synthesis and adjuvant vs antibiotic antibacterial evaluation
Jessica R. Gutiérrez Cano, I. Paulina Morales-Sandoval, Dino Gnecco, et al.
Results in Chemistry (2024) Vol. 7, pp. 101366-101366
Open Access
Delaying cefiderocol resistance development in NDM-producingEnterobacter cloacaecomplex by combining cefiderocol with aztreonamin vitro
Lisa Göpel, Minh Thu Tran Nguyen, Tung Tran Thanh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Successful eradication of an environmental reservoir of NDM-producing Klebsiella pneumoniae associated with nosocomial transmissions in a low-incidence setting
Estelle Moulin, Paraskevas Filippidis, Corinne Aymon Paire-Ficout, et al.
Research Square (Research Square) (2024)
Open Access
Synergistic Combination of Aztreonam and Ceftazidime–Avibactam—A Promising Defense Strategy against OXA-48 + NDM Klebsiella pneumoniae in Romania
Ioana Miriana Cismaru, Maria Cristina Văcăroiu, Elif Soium, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 550-550
Open Access
Clinical relevance of Staphylococcus saccharolyticus detection in human samples: a retrospective cohort study
Ricarda Michels, Cihan Papan, Sébastien Boutin, et al.
Infection (2024)
Open Access
Bio Inspired Microfluidic-Based Analysis of Klebsiella pneumoniae Virulence Factors and Antimicrobial Resistance
Xiaoping Song, Jun Zhang, Weihong Hua, et al.
SLAS TECHNOLOGY (2024) Vol. 29, Iss. 6, pp. 100209-100209
Open Access

Scroll to top